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Central nervous system (CNS) has a highly specialized microenvironment, and
despite being initially considered an immune privileged site, this immune status
is far from absolute because it varies with age and brain topography. The brain
monitors immune responses by several means that act in parallel; one pathway
involves afferent nerves (vagal nerve) and the other resident cells (neurons and
glia). These cell populations exert a strong role in the regulation of the immune
system, favoring an immune-modulatory environment in the CNS. Neurons control
glial cell and infiltrated T-cells by contact-dependent and -independent mechanisms.
Contact-dependent mechanisms are provided by several membrane immune modulating
molecules such as Sema-7A, CD95L, CD22, CD200, CD47, NCAM, ICAM-5, and cadherins;
which can inhibit the expression of microglial inflammatory cytokines, induce apoptosis or
inactivate infiltrated T-cells. On the other hand, soluble neuronal factors like Sema-3A,
cytokines, neurotrophins, neuropeptides, and neurotransmitters attenuate microglial
and/or T-cell activation. In this review, we focused on all known mechanism driven only
by neurons in order to control the local immune cells.
Keywords: neuronal immune modulation, central nervous system, neuron-microglia interaction, neuron-T cell
interaction, CD200, neurotrophins, neurotransmitters, semaphorins
INTRODUCTION
The central nervous system (CNS) has a highly specialized
immune-modulatory microenvironment, which has developed
several mechanisms to protect itself from immune-mediated
inflammation. This microenvironment is sustained by existing
physiological and anatomical elements such as the blood-brain
barrier (BBB) that limits peripheral immune cells and molecules
entry; the afferent nerves of the autonomic nervous system
with anti-inflammatory properties; and finally, the resident cells
like astrocytes and neurons, which also contribute to the local
immune privilege through the expression of anti-inflammatory
suppressive factors and cell surface molecules (Carson et al.,
2006).
The ability of neurons to sense changes in the brain and the
body is a key factor in maintaining CNS-homeostasis. There is a
large body of evidence that immune and neuronal systems com-
municate with each other by soluble factors as neurotransmit-
ters, neuromodulators, and neuropeptides, or through cell-cell
contact by neuroimmune regulatory molecules that can reduce
or inhibit any exacerbated inflammatory response (Tian et al.,
2009).
In this review, we focus on the general neuron-cell contact-
dependent and contact-independent mechanisms involved in the
immune modulation in order to maintain CNS immune privi-




Neurons can display an array of membrane molecules in order
to control local immune functions; these molecules can tar-
get local immune cells like microglia and astrocytes or periph-
eral immune cells present in the CNS. When BBB is ruptured,
immune privilege is lost and neurons may come in contact with
T or mononuclear cells, endangering their survival. However,
neurons might modulate these immune cells by several strate-
gies, either indirectly suppressing T-cell activation by restric-
tion of antigen presenting properties of glial cells, directly sup-
pressing T-cell activation, favoring a Th2 profile or promot-
ing apoptosis of activated microglia and T-cells (Tian et al.,
2009).
MOLECULES INHIBITING GLIAL ACTIVATION
The neuronal cell adhesion molecule (NCAM/CD56) is expressed
on the surface of neurons, astrocytes and microglia (Sporns et al.,
1995; Krushel et al., 1998; Chang et al., 2000a,b), and has a critical
role in cell-cell adhesion, synaptic plasticity, neurite outgrowth,
among other processes (Tian et al., 2009). Astrocyte-neuron
interactions via NCAM lead to modulate glial scar formation
by the inhibition of astrocyte proliferation in vitro and in vivo
after performed stab lesions in the striatum, cerebral cortex,
or hippocampus (Krushel et al., 1995, 1998). NCAM requires
the activation of the glucocorticoid receptor to inhibit growth
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factor-induced mitogen activated protein kinase (MAPK) activity
and therefore preventing astrocytic proliferation (Krushel et al.,
1998). NCAM also modulates microglial activation, decreases the
production of TNFα and nitric oxide (NO) after glial stimulation
with lipopolysaccharide (LPS) by reducing the expression of tran-
scription factors like c-Jun, among others (Chang et al., 2000a,b).
For the mediation of glial immune responses the homophilic
binding of third Ig domain of NCAM is crucial (Sporns et al.,
1995; Krushel et al., 1998).
Another important molecule thought to contribute to the
constitutive anti-inflammatory and regulatory environment of
the brain is CD200, a highly expressed glycoprotein in the
CNS, mainly in neurons (Chitnis et al., 2007; Koning et al.,
2009). Neuronal CD200 down-modulates the activation state
of perivascular macrophages and microglia trough the CD200
receptor (Hoek et al., 2000). Upon binding to its ligand, the
tyrosine residues on the cytoplasmic tail of CD200R are phos-
phorylated and the downstream signaling leads to inhibition of
p38 MAPK, c-Jun N-terminal kinase (JNK), and extracellular-
signal-regulated kinases (ERK; Zhang et al., 2004), interfering
with the activation of macrophages and microglia. Moreover,
IL4 mediated neuronal CD200 expression maintains microglia
in a quiescent state and anti-inflammatory/neuroprotective pro-
file (Lyons et al., 2009). Additionally, aging leads to a depressed
CD200 expression and microglial activation, favoring a pro-
neurodegenerative disease environment (Cox et al., 2012). Also,
defects in CD200-CD200R pathway play a critical role in neurode-
generative disease development such as multiple sclerosis (MS),
Parkinson’s and Alzheimer’s diseases (Koning et al., 2007; Walker
et al., 2009; Zhang et al., 2011).
CD22 is a regulatory sialic-acid-binding molecule that medi-
ates neuron binding to microglia through CD45, inhibiting
CD40L-induced microglial activation by suppression of the p38
and p44/42 MAPK signaling pathway and preventing microglial
TNFα production after LPS stimulation (Tan et al., 2000; Mott
et al., 2004; Zhu et al., 2008).
Neuronal membrane integrin-associated protein (CD47) is
specially concentrated on synapses and exerts its neuroimmune
functions mainly via two receptors (Tian et al., 2009). CD172
(SIRPα) ligation results in phosphatidylinositide 3-kinase (PI3K)
signaling cascade activation, and reduces inflammation sever-
ity by increasing TGFβ levels, diminishing phagocytosis TNFα
and INFα levels (Reinhold et al., 1995; Smith et al., 2003).
Furthermore, decreased levels of CD47 are found in chronic active
and inactive MS lesions, possibly favoring persistence of damage
by the lack of regulation of activated microglia and macrophages
(Koning et al., 2007). CD47 interaction with thrombospondin
TSP, a further receptor, leads to T-cell and microglia apoptosis via
CD95/CD95L pathway also reducing inflammation (Lamy et al.,
2007).
Residential brain cells express CD95L (FasL) constitutively
to limit possible damaging inflammatory responses. Neuronal
CD95L expression induces apoptosis of infiltrating and autore-
active T-cells (Flügel et al., 2000), as well of activated microglia
(Choi and Benveniste, 2004). Additionally, CD95L protects neu-
rons from perforin-mediated T-cell cytotoxicity (Medana et al.,
2001).
The expression of chemokine CX3CL1 (fractalkine) and
its receptor CX3CR1 is limited to neurons and microglia,
respectively (Hughes et al., 2002). CX3CL1 can be found
membrane-anchored or secreted both in physiological and patho-
logical conditions such as facial motor nerve axotomy or a toxic
model of Parkinson’s disease (Harrison et al., 1998; Cardona et al.,
2006). CX3CL1-CX3CR1 interactions lead to the JNK MAPK
pathway activation and Nrf2 recruitment suppressing the neu-
rotoxic microglia activity and reducing neuronal death due to
inflammation (Zujovic et al., 2000; Mizuno et al., 2003; Cardona
et al., 2006; Noda et al., 2011).
MOLECULES INHIBITING IMMUNE CELLS
Plexin and semaphorin signaling has revealed that several
members of this family are involved in immune cell pro-
cesses. Among these semaphorins are Sema-3A, Sema-3E, Sema-
4D, Sema-4A, Sema-6D, and Sema-7A (Roney et al., 2013).
However, only Sema-3A and Sema-7A are expressed by neu-
rons, respectively either as secreted or membrane-bound reg-
ulatory proteins that attenuate T-cell activation, proliferation,
and function through T-cell receptor (TCR) signaling (Czopik
et al., 2006; Lepelletier et al., 2006). Sema-3A exerts its action
forming a complex with neuropilin-1 and plexin-A1 that leads
to the prevention of immune response over-activation and
the inhibition of human monocytes migration through the
blockage of actin cytoskeleton reorganization, interfering with
TCR polarization and signal transduction events by down-
modulation of MAPK signaling cascades (Lepelletier et al.,
2006). Also stressed neurons may induce apoptosis of INFγ or
LPS activated microglia through Sema-3A secretion recruiting
CD95 to lipid rafts next to neuropilin-1 (Majed et al., 2006;
Moretti et al., 2008). Sema-7A, a glycosylphosphatidylinositol-
linked semaphorin, negatively regulates TCR signaling and
avoids activation of the ERK-MAPK pathway decreasing T-cell
FIGURE 1 | Neuronal microglia and T-cell regulation. Neurons control
T-cell and glia functions through neuronal membrane molecules or
constitutive-secreted molecules like neurotrophins, neurotransmitters,
neuropeptides, semaphorins, and cytokines, constituting
contact-dependent and -independent regulatory mechanisms.
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proliferation. Sema-7A deficient mice present T-cell hyperre-
sponsiveness and hyperproliferation with severe experimen-
tal autoimmune encephalomyelitis pathology (Czopik et al.,
2006).
Additionally, N- and E-cadherins are highly expressed in the
CNS and bind to the killer cell lectin-like receptor G1 (KLRG1)
on NK- and T-cells, preventing NK lysis of neurons and suppress-
ing CD8 + T-cells antigenic proliferation and cytolytic activity
(Gründemann et al., 2006; Ito et al., 2006).
Only soma and dendrites of neurons express the intercellular
adhesion molecule-5 (ICAM-5/telencephalin; Tian et al., 2000).
Neurons bind to T-cell through the ICAM-5-CD11a/Cd18 (LFA-
1) interaction diminishing TCR dependent T-cell activation and
enhancing TGFβ and INFγ expression in naïve T-cells (Tian et al.,
2008). Additionally, ICAM-5 can be cleaved by activated T-cell or
microglial-secreted matrix metalloproteinases-2 and -9, soluble
ICAM-5 may compete with ICAM-1 costimulatory signal neces-
sary for T-cell activation (Tian et al., 2008). Also, soluble ICAM-5
is present in blood and cerebrospinal fluid after hypoxia due to
carotid artery ligation in mice and acute encephalitis in humans
(Guo et al., 2000; Lindsberg et al., 2002). Moreover, ICAM-5
regulates microglia morphology and function by facilitating cell
spreading and increasing CD11a/Cd18 expression (Mizuno et al.,
1999).
NEURON-MEDIATED GENERATION OF REGULATORY T-CELLS
Regulatory T-cells (Tregs) are important in keeping CNS home-
ostasis in healthy and pathological conditions, and are also locally
induced by glia cells and neurons (Liu et al., 2006; Saenz et al.,
2010). Encephalitogenic T-cell production of IFNγ and TNFα
leads to neuronal expression of TGFβ1, CD80, and CD86, which
induce encephalitogenic CD4 + T-cells to become Tregs, in a
cell-to-cell dependent and antigen independent way through the
TGF-β1–TGF-βR and TCR signaling pathway (Issazadeh et al.,
1998; Liu et al., 2006). Neuron-induced Tregs are able to inhibit
progression of experimental autoimmune encephalomyelitis by
suppression of encephalitogenic CD4+ T-cells proliferation (Liu
et al., 2006).
Table 1 | Main neuronal immune regulatory molecules, their receptors and target cells in the CNS.
Neuronal molecule Target cell Receptor References
CADHERIN SUPERFAMILY
E-cadherin NK-cell, T-cell KLRG1 Gründemann et al., 2006; Ito et al., 2006
N-cadherin NK-cell, T-cell KLRG1 Ito et al., 2006
IMMUNOGLOBULIN SUPERFAMILY MOLECULES
CD22 Microglia CD45 Mott et al., 2004
CD47 Microglia CD172a, TSP Smith et al., 2003; Lamy et al., 2007
CD200 Microglia CD200R Hoek et al., 2000; Rijkers et al., 2008
ICAM-5 T-cell CD11a/Cd18 Mizuno et al., 1999; Tian et al., 2000, 2008
NCAM Microglia, Astrocyte NCAM Sporns et al., 1995; Krushel et al., 1998; Chang et al., 2000a
TUMOR NECROSIS FACTOR FAMILY
CD95L Microglia, T-cell CD95 Choi and Benveniste, 2004
CYTOKINES AND CHEMOKINES
IL10 Microglia, T-cell IL10R Strle et al., 2001
TGFβ Microglia, T-cell TGFβR Pratt and McPherson, 1997; Liu et al., 2006
CX3CL1 Microglia CX3CR1 Hughes et al., 2002
NEUROTRANSMITTERS AND NEUROPEPTIDES
GABA Microglia GABAA, GABAB Färber and Kettenmann, 2005
Dopamine Microglia, T-cell D1, D2, D3, D4, D5 Färber et al., 2005
NE Microglia, Astrocyte, T-cell α1A, α2A, β1, β2 Färber et al., 2005; Gyoneva and Traynelis, 2013
VIP Astrocyte, T-cell VPAC1, VPAC2 Delgado et al., 2004, 2008
NEUROTROPHINS
NGF Microglia, Astrocyte p75, NTR, TrkA Neumann et al., 1998; Althaus and Richter-Landsberg, 2000;
Cragnolini et al., 2012
BDNF Microglia, Astrocyte p75, NTR, TrkB Neumann et al., 1998; Althaus and Richter-Landsberg, 2000
NT-3 Microglia p75, NTR, TrkB, TrkC Neumann et al., 1998; Althaus and Richter-Landsberg, 2000;
Tzeng and Huang, 2003
SEMAPHORINS
Sema-3A Microglia, T-cell Neuropilin-1 and plexin-A1 Lepelletier et al., 2006
Sema-7A T-cell Plexin-C1, α1β1 integrin Czopik et al., 2006
BDNF, brain-derived neurotrophic factor; ICAM-5, intercellular adhesion molecule-5; GABA, γ-aminobutyric acid; NCAM, neuronal cell adhesion molecule; NE,
norepinephrine; NGF, nerve growth factor; NT-3, neurotrophin-3; Sema-3A, semaphorin-3A; Sema-7A, semaphorin-7A; VIP, vasoactive intestinal peptide.
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CONTACT INDEPENDENTMECHANISMS FOR IMMUNE
MODULATION
Constitutive-secreted neurotrophins, neurotransmitters, and
neuropeptides, as well as cytokines provide contact-independent
routes for neurons to control microglial and T-cell activities.
Neurotrophins play a critical role in the control of neu-
ronal survival, migration, and differentiation and modu-
late immune cell functions (Tabakman et al., 2004). Nerve
growth factor (NGF), brain-derived neurotrophic factor (BDNF),
and neurotrophin-3 (NT-3) can inhibit MHCII expression in
microglia in hippocampal slice cultures via the low affinity
p75 neurotrophin receptor (Neumann et al., 1998). NGF also
down-regulates the co-stimulatory molecules CD40 and CD86
in microglia (Wei and Jonakait, 1999), is increased in cerebral
spinal fluid of MS patients (Laudiero et al., 1992), and NGF
treatment delays EAE onset and clinical severity (Arredondo
et al., 2001). In addition, NGF arrests astrocyte cell cycle possi-
bly restricting glial scar formation after CNS injury via the p75
neurotrophin receptor, attenuating cyclins D1 and E and pre-
venting the degradation of cyclin-dependent kinase inhibitors
p15INK and p27kip1 (Cragnolini et al., 2012). Interestingly, NT-
3 has anti-inflammatory properties by diminishing microglial
inducible form of NO synthase, NO, IL1-β, and TNFα lev-
els, and phagocytic activity after LPS stimulation. NT-3 exerts
its effects mainly through the TrkC receptor leading to the
activation of MAPK and PI3K cascades and decreasing the
NFκB-p65 activity (Tzeng and Huang, 2003; Tzeng et al.,
2005).
IL10 and TGFβ cytokines have anti-inflammatory and sup-
pressive properties that importantly regulate CNS inflammatory
responses and resident cells survival (Pratt and McPherson, 1997;
Strle et al., 2001). Both cytokines and their receptors are expressed
by neurons and glial cells throughout the CNS (Szelényi, 2001).
These regulatory molecules down-regulate microglia inhibiting
the expression of MHCII, pro-inflammatory cytokines such as
TNFα and IL1β, as well as NO synthesis after LPS activation
(Suzumura et al., 1993; Sawada et al., 1999; Heyen et al., 2000).
Furthermore, IL10 and TGFβ have an important role on Tregs
and keep autoimmune T-cells under the steady state (Saenz et al.,
2010).
Among the neuropeptides and neurotransmitters with mod-
ulatory properties that inhibit microglial LPS-induced pro-
inflammatory factors like IL1β, IL6, TNFα, and NO, are
vasoactive intestinal peptide (VIP), dopamine, norepinephrine
(NE), and γ-aminobutyric acid (GABA; Färber et al., 2005;
Bjurstöm et al., 2008; Delgado et al., 2008). VIP exerts its
anti-inflammatory effects through the VPAC1 and VPAC2 recep-
tors inhibiting p38 and p42/p44 MAPK and NFκB signaling
cascades (Delgado et al., 2008). Also, VIP treatment avoids
beta-amyloid neurodegeneration and MPTP-induced dopamin-
ergic neuronal loss (Delgado and Ganea, 2003; Delgado et al.,
2008). Additionally; VIP induces protective TH2 cells by up-
regulation of macrophage B7.2 expression and Tregs in a EAE
model (Delgado et al., 2004; Fernandez-Martin et al., 2006).
Physiological concentrations of GABA activate functional GABAA
channels on encephalitogenic T-cell decreasing cell proliferation,
while GABAB channels activation on microglia attenuates IL6
and IL 12p40 levels after LPS stimulation (Kuhn et al., 2004;
Bjurstöm et al., 2008). Functional dopamine receptors D1 and
D2 are expressed by microglia and their activation lead to atten-
uate NO production after LPS stimulation (Kuhn et al., 2004).
CNS NE levels are relevant in order to maintain tissue home-
ostasis since NE loss contributes to neuroinflammatory processes
that lead to neurodegenerative diseases, for instance depressed
mice with low NE levels respond with higher TNFα production
after LPS stimulation while increasing NE levels are necessary
to reduce EAE severity (Szelényi and Vizi, 2007; Simonini et al.,
2010). Moreover, NE regulates microglia morphology and motil-
ity by microglial processes retraction; in this dynamic process the
β2 and α2A receptors are involved in resting cells and activated
microglia cells, respectively (Gyoneva and Traynelis, 2013).
CONCLUSIONS
Traditionally glial cells are considered to be responsible for the
regulation of immune processes in the CNS.Nevertheless neurons
contribute to immune modulation through contact-dependent
and -independent mechanisms (Figure 1). Several neuronal
secreted as well-membrane associated molecules (Table 1) are
implicated in the control of glial and T-cell functions, thus
contributing to CNS immune privilege.
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